R
Rallybio Corp
NASDAQ:RLYB
Rallybio Corp
NASDAQ:RLYB
Price:
8.3
USD
-1.66%
Market Closed
Market Cap:
$43.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Rallybio Corp
NASDAQ:RLYB
|
US |
|
I-O Data Device Inc
TSE:6916
|
JP |
|
Stillfront Group AB (publ)
STO:SF
|
SE |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
|
Banco do Estado de Sergipe SA
BOVESPA:BGIP3
|
BR |
|
Tai Hing Group Holdings Ltd
HKEX:6811
|
HK |
|
Yuhan Corp
KRX:000100
|
KR |
|
P
|
Pomi Frutas SA - em Recuperacao Judicial
BOVESPA:FRTA3
|
BR |
|
G
|
Gujarat Intrux Ltd
BSE:517372
|
IN |
|
Hwang Chang General Contractor Co Ltd
TWSE:2543
|
TW |
|
F
|
Farm Fresh Bhd
KLSE:FAVCO
|
MY |
|
D
|
Dongnam Chemical Co Ltd
KRX:023450
|
KR |
|
A
|
Asahi Intecc Co Ltd
TSE:7747
|
JP |
|
Adisyn Ltd
ASX:AI1
|
AU |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
|
Freelance.com SA
PAR:ALFRE
|
FR |
|
Vladimirskiy Khimicheskiy Zavod PAO
MOEX:VLHZ
|
RU |
|
I
|
Inest Inc (Ikebukuro)
TSE:7111
|
JP |
|
S
|
Structural Monitoring Systems PLC
ASX:SMN
|
AU |
Balance Sheet
Balance Sheet Decomposition
Rallybio Corp
Rallybio Corp
Balance Sheet Decomposition is not available for
Rallybio Corp
Rallybio Corp
Balance Sheet
Rallybio Corp
Rallybio Corp
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
20
|
140
|
175
|
57
|
24
|
14
|
31
|
|
| Cash Equivalents |
20
|
140
|
175
|
57
|
24
|
14
|
31
|
|
| Short-Term Investments |
0
|
0
|
0
|
112
|
85
|
52
|
23
|
|
| Other Current Assets |
2
|
1
|
6
|
11
|
5
|
2
|
7
|
|
| Total Current Assets |
21
|
141
|
181
|
180
|
115
|
68
|
61
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Long-Term Investments |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
22
N/A
|
142
+557%
|
182
+28%
|
180
-1%
|
116
-36%
|
68
-41%
|
62
-9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
1
|
1
|
1
|
0
|
0
|
|
| Accrued Liabilities |
3
|
4
|
6
|
10
|
8
|
5
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Current Liabilities |
4
|
6
|
7
|
11
|
9
|
6
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
6
+26%
|
7
+12%
|
11
+68%
|
9
-15%
|
6
-32%
|
4
-33%
|
|
| Equity | ||||||||
| Common Stock |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
21
|
47
|
94
|
161
|
235
|
293
|
302
|
|
| Additional Paid In Capital |
0
|
0
|
270
|
330
|
341
|
355
|
360
|
|
| Other Equity |
37
|
182
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
17
N/A
|
136
+705%
|
176
+29%
|
169
-4%
|
106
-37%
|
62
-42%
|
58
-6%
|
|
| Total Liabilities & Equity |
22
N/A
|
142
+557%
|
182
+28%
|
180
-1%
|
116
-36%
|
68
-41%
|
62
-9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
1
|
4
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
